ISS Stage III Plasma Cell Myeloma

Known as: Multiple Myeloma Stage III, International Staging System Stage III Multiple Myeloma, International Staging System Stage III Plasma Cell Myeloma 
Plasma cell myeloma with beta-2-microglobulin greater than or equal to 5.5 (median survival of 29 months). Note that the older Durie/Salmon staging… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2016
012319882016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
BACKGROUND Data from randomized, controlled trials of zoledronic acid were retrospectively analyzed to assess the effect of… (More)
Is this relevant?
Review
2003
Review
2003
Technetium-99m 2-methoxyisobutylisonitrile (99mTc-MIBI) is a lipophilic agent that has been proposed as a useful tracer for the… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE Zoledronic acid, a new and more potent bisphosphonate, was compared with pamidronate, the current standard treatment for… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Primary plasma cell leukemia (PCL) is a rare plasma cell malignancy. Consequently, few large reports have been published… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
In a double blind randomized study, the bisphosphonate drug Pamidronate (Aredia) significantly protected Durie–Salmon stage III… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1997
1997
  • Bo Zhu, S Liu
  • Zhonghua zhong liu za zhi [Chinese journal of…
  • 1997
OBJECTIVE To evaluate the efficacy and toxicites of combination chemotherapy of teniposide, cyclophosphamide, and dexamethasone… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND Skeletal complications are a major clinical manifestation of multiple myeloma. These complications are caused by… (More)
Is this relevant?
1995
1995
Double hemibody irradiation (DHBI) is an alternative treatment of stage III multiple myeloma (MM) in patients aged over 55 years… (More)
Is this relevant?
1992
1992
To study the efficiency of high-dose melphalan in previously untreated patients with advanced myeloma, we performed a Phase I-II… (More)
Is this relevant?
1988
1988
The advanced forms of multiple myeloma of bone, stage III, or those with a large tumoral mass, characterized by a considerable… (More)
Is this relevant?